11 Pharmaceutical Marketing Expert Witnesses Found

Results Sorted Below by State

John J Hosier John Hosier Healthcare Consulting, LLC

California
Marketing, Management - Bio-similar drugs, Biotech & Pharma Marketing, Operations, Branded Promotion, CNS Products, Medicare, Oncology Products, Pharma Commercialization, Pharmaceutical Contracting & Pricing, Pharmaceutical Launch, Pharma Marketing, Pharma Sales, Specialty Pharma, DTC, Commercially Reasonable Efforts, CRE
...Hosier is a strategic advisor to the life sciences industry drawing on more then 26 years of sales, marketing and managed markets experience in commercial healthcare organizations. He has provided insights to small molecule & biotechnology companies across multiple therapeutic areas but has maintained a heavy concentration in oncology and specialty pharmaceuticals. He has led brand launch; corporate, franchise, and strategic brand planning; commercial integration; organizational design; and operational effectiveness from multiple perspectives (as the client, as the independent consultant, and as an agency lead). Mr....

Daniel E Buffington, PharmD, MBA, FAPhA Clinical Pharmacology Services, Inc.

Tampa, Florida
Pharmacology- Clinical, Toxicology - Autopsy, Capital Crimes, Controlled Substance, Dispensing, DUI, Dramshop, Drug Screen, Evidence, Medication Therapy Management, Pain Management, Pharmacology, Postmortem, Toxicology, Trafficking, Prescribing, Prescribing, Side Effects, Substance Use Disorders, Therapeutic Drug Monitoring
...Faculty - University of South Florida Specialty Focus: Adverse Side Effects Autopsy & Postmortem Analysis Capital Crimes Causation Court Ordered Clinical Evaluations DEA & Controlled Substances Drug Benefit Design and Medication Access Drug Research & FDA Approval Drug Screening & Test Analysis Drug Trafficking & Deaths DUI & Dramshop Evidence Sample Analysis Medication Therapy Management Pain Management Parenting and Child Custody Pharmaceutical Marketing and Patents Pharmacology & Toxicology Prescribing And Dispensing Errors Psychopharmacology Standard of Care “Prescribing” Substance Use Disorders Therapeutic Drug Monitoring

Tim Kamerzell, MD, PhD

Overland Park, Kansas
Hospitalist, Internal Medicine - Hospital Medicine, General Internal Medicine, Telemedicine, Perioperative Medicine, Medical Devices, Pharmaceutical Research and Development, Pharmaceutical Regulation, Chemistry, Biochemistry,
...He currently serves in various leadership roles including the Vice Chair of the Department of Medicine for Overland Park Regional Medical Center, Physician Advisory Board Member and Facility Lead Physician for the Overland Park Market of HCA Healthcare, Inc. Dr. Kamerzell received a PhD in Pharmaceutical Chemistry from the University of Kansas and has extensive experience working in the pharmaceutical industry as a research scientist at Genentech, Inc. Dr. Kamerzell completed research fellowships at Harvard Medical School and Mount Sinai School of Medicine in the areas of drug discovery and design, cardiovascular disease, and electrophysiological mechanisms of cardiac arrhythmias. He remains active in research and works as a consultant to multiple pharmaceutical and biotechnology companies. Dr. Kamerzell has several patents related to the design of novel therapeutics and has published extensively in peer reviewed chemistry journals....

Ilonna J. Rimm, MD PhD CFA Rimm Healthcare Capital Advisory LLC

Newton Center, Massachusetts
Financial, Pediatric Hematology Oncology - Appraisal and Valuation, Banking, Business Valuation, DNA, Financial, Securities and Investments, Biotechnology, Medical Devices, Healthcare Services, Life Science Tools , Pharmaceuticals , Entrepreneurial Companies, Start-up companies
...As the CEO and Founder of Morninglight Healthcare Capital, LLC, a family office, she invests in small cap public companies (0 to $4B market cap). She also serves as an Advisor to Life Sciences CEO’s who are raising a Seed or Series A Round of capital, as Rimm Healthcare Capital Advisory, LLC. She can fully understand the biological science of an emerging company. Then she can organize and polish the science to present it in a way that is attractive to life science investors. She recently provided services to Immuneering Corp., who raised a Series A round of $20M in January, 2020, and a Series B round of $62M in January, 2021. Immuneering is now a public company (IMRX). Ilonna currently work as a Financing Expert at the Harvard Innovation Lab, which is associated with Harvard Business School....

Magdy M. Abdel-Malik, Ph.D. Quaestio Global Partners LLC

Chester, New Jersey
Pharmaceutical Research, Chemistry & Chemicals - Analytical chemistry , Drug delivery systems , Natural products chemistry, Oral cavity health, Chemicals characterization, Hair care, Smoking cessation, Cosmetic products, innovation assessment, Organic chemistry, Dietary supplements, Intellectual property (IP) , Over the counter (OTC) medicines
...His expertise lies in the intersection of R&D and business development in the life sciences, particularly in pharmaceuticals and consumer products. PHARMACEUTICALS AND CONSUMER PRODUCTS: AREAS OF EXPERTISE Dr. Abdel-Malik has developed comprehensive expertise across diverse therapeutic areas within pharmaceuticals and consumer products....

John J Hosier John Hosier Healthcare Consulting, LLC

West New York, New Jersey
Marketing, Management - Bio-similar drugs, Biotech & Pharma Marketing, Operations, Branded Promotion, CNS Products, Medicare, Oncology Products, Pharma Commercialization, Pharmaceutical Contracting & Pricing, Pharmaceutical Launch, Pharma Marketing, Pharma Sales, Specialty Pharma, DTC, Commercially Reasonable Efforts, CRE
...Hosier is a strategic advisor to the life sciences industry drawing on more then 26 years of sales, marketing and managed markets experience in commercial healthcare organizations. He has provided insights to small molecule & biotechnology companies across multiple therapeutic areas but has maintained a heavy concentration in oncology and specialty pharmaceuticals. He has led brand launch; corporate, franchise, and strategic brand planning; commercial integration; organizational design; and operational effectiveness from multiple perspectives (as the client, as the independent consultant, and as an agency lead). Mr....

John J Hosier John Hosier Healthcare Consulting, LLC

New York
Marketing, Management - Bio-similar drugs, Biotech & Pharma Marketing, Operations, Branded Promotion, CNS Products, Medicare, Oncology Products, Pharma Commercialization, Pharmaceutical Contracting & Pricing, Pharmaceutical Launch, Pharma Marketing, Pharma Sales, Specialty Pharma, DTC, Commercially Reasonable Efforts, CRE
...Hosier is a strategic advisor to the life sciences industry drawing on more then 26 years of sales, marketing and managed markets experience in commercial healthcare organizations. He has provided insights to small molecule & biotechnology companies across multiple therapeutic areas but has maintained a heavy concentration in oncology and specialty pharmaceuticals. He has led brand launch; corporate, franchise, and strategic brand planning; commercial integration; organizational design; and operational effectiveness from multiple perspectives (as the client, as the independent consultant, and as an agency lead). Mr....

Gary S. Barach, CPA, CFE, CFF, CVA BCG Forensics, LLC

West Chester, Pennsylvania
Business Damages, Economics - fraud, business valuation, business interruption, lost profits, product recall, personal injury, employment cases, discrimination, contract disputes, dispute resolution, economic damages, construction defects, insurance claims, class action, shareholder disputes, bankruptcy, commercial litigation.
...Barach’s 40 years of experience includes diverse industries such as telecommunication; hospitality; health care; sport franchises; construction; retail; pharmaceutical manufacturing and distribution; and oil, gas and mining. Examples of cases are as follows: Intellectual Property and Valuation: Determination of Fair Market Value of the Brand “Platinum”, arising from a dispute between two national software developers. Product Liability: Economic damages to an international manufacturer of diesel locomotives due to defects in supplied engine components. Economic damages arising from the recall of pet food due to contaminated wheat gluten imported from China. Construction: Economic damages to a resort from defects in structural material resulting in additional costs to construct and lost profits due to delay in opening. Fraud and Arson: Amounts embezzled by a bank manager and methods used....

John J Hosier John Hosier Healthcare Consulting, LLC

Pennsylvania
Marketing, Management - Bio-similar drugs, Biotech & Pharma Marketing, Operations, Branded Promotion, CNS Products, Medicare, Oncology Products, Pharma Commercialization, Pharmaceutical Contracting & Pricing, Pharmaceutical Launch, Pharma Marketing, Pharma Sales, Specialty Pharma, DTC, Commercially Reasonable Efforts, CRE
...Hosier is a strategic advisor to the life sciences industry drawing on more then 26 years of sales, marketing and managed markets experience in commercial healthcare organizations. He has provided insights to small molecule & biotechnology companies across multiple therapeutic areas but has maintained a heavy concentration in oncology and specialty pharmaceuticals. He has led brand launch; corporate, franchise, and strategic brand planning; commercial integration; organizational design; and operational effectiveness from multiple perspectives (as the client, as the independent consultant, and as an agency lead). Mr....

Debra Leibold, MD, PhD Consultant

Blue Bell, Pennsylvania
Pharmaceutical Regulation, Warnings & Labels - Pharmaceutical Industry, Drug Development, Product Labeling, Regulatory Labeling, Prescribing Information, Indications, Dosage, Contraindications, Warnings, Precautions, Adverse Experiences, Regulatory Compliance, Safety, FDA, Off-label Use
Ethical Full Lifecycle Labeling/Prescribing Information That Never Cuts Corners For Pharmaceutical Giants Merck, Shire, and J&J: Labeling strategy and leadership that brings product labeling and products to market supporting vaccines and treatments for infections, internal medicine, oncologic, and rare diseases. These include life-saving, ground breaking, and first-of-its-kind products. Bring decision makers across divisions to the table to negotiate resolution of labeling issues - leading to the creation, revision, and maintenance of clear and compliant product labels that educate health care professionals and patients in the US, EU, Japan, and Rest of World. Gain consensus and champion proactive consensus-building across Research, Statistics, Regulatory, Joint Ventures, Legal, and Marketing on labeling - laser-focused on the bottom line: “What do the doctor and patient need to know?”...

Eileen E. Ming, MPH, ScD, FISPE Epi Excellence LLC

Garnet Valley, Pennsylvania
Public Health, Pharmaceutical Research - epidemiology, pharmacoepidemiology, outcomes research, observational research, real world evidence
...Ming, MPH, ScD, FISPE, is an epidemiologist, pharmacoepidemiologist, outcomes researcher, and leader in the pharmaceutical industry. She served as an outcomes researcher at Merck, an epidemiologist at AstraZeneca, and the head of global epidemiology and pharmacoepidemiology at Shire Pharmaceuticals. Dr. Ming founded Epi Excellence, an epidemiology consulting practice, in 2014. She has worked across a variety of therapeutic areas, from pre-clinical through post-marketing phases, providing epidemiologic strategic and tactical expertise to commercial, clinical development, market access, medical affairs, regulatory, and pharmacovigilance activities. Dr. Ming is an Adjunct Scholar of the Center for Clinical Epidemiology and Biostatistics, and an Adjunct Investigator of the Center for Pharmacoepidemiology Research and Training, at the Perelman School of Medicine at the University of Pennsylvania. She is a Fellow of the International Society for Pharmacoepidemiology. Dr....